AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program
Testimony
Every day, AHA staff take to Capitol Hill to tell the hospital story, working to educate Congress on key issues and the field’s concerns. We also advocate with federal regulators, provide expert testimony, and highlight the impact proposed changes could have and suggest alternative solutions. Below are the most recent statements the AHA has submitted for the record for congressional hearings or agency panels.